XML 50 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2024
Alfmeier  
Business Acquisition [Line Items]  
Summary of Product Revenues and Operating Income

The following table provides product revenues and operating income from Alfmeier that are included in our consolidated financial statements for the year ended December 31, 2022, following the August 1, 2022 acquisition date:

 

 

Year Ended December 31,

 

 

 

2022

 

Product revenues

 

$

98,960

 

Net loss

 

 

(2,675

)

 

Summary of Unaudited Pro Forma Information

The following unaudited pro forma information represents our product revenues and net income as if the acquisition of Alfmeier had occurred as of January 1, 2022:

 

 

Year Ended December 31,

 

 

 

2022

 

Product revenues

 

$

1,348,295

 

Net income

 

 

17,645

 

Dacheng  
Business Acquisition [Line Items]  
Summary of Product Revenues and Operating Income The results of Dacheng's operations are reported within the Medical segment from the acquisition date.

The following table provides product revenues and operating income from Dacheng that are included in our consolidated financial statements for the year ended December 31, 2022, following the July13, 2022 acquisition date:

 

 

Year Ended December 31,

 

 

 

2022

 

Product revenues

 

$

3,499

 

Net loss

 

 

(217

)